Neurocrine Biosciences Insider Sold Shares Worth $2,603,112, According to a Recent SEC Filing
Ingrid Delaet, Chief Regulatory Officer, on July 07, 2026, sold 14,571 shares in Neurocrine Biosciences (NBIX) for $2,603,112. Following the Form 4 filing with the SEC, Delaet has control over a total of 16,225 common shares of the company, with 16,225 shares held directly. SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.